Table 3.
Serum level of MDA, TAC, T4, TSH among study groups.
| Variables | Groups |
p-value | ||
|---|---|---|---|---|
| Group A (newly diagnosed hyperthyroid patient) (n = 25) |
Group B (hyperthyroidism with carbimazole) (n = 25) | Group C (hyperthyroidism treated with carbimazole and antioxidant) (n = 25) |
||
| MDA (μmol/L) | 4.60 ± 1.08 | 2.79 ± 0.58 | 1.57 ± 0.29 | <0.001 |
| TAC (μmol/L) | 527.8 ± 78.44 | 951.80 ± 99.67 | 1113.56 ± 121.69 | <0.001 |
| T4 (fmol/ml) 8.56–25.6 fmol/ml |
114.64 ± 48.21 | 17.20 ± 7.18 | 14.33 ± 4.32 | <0.001 |
| TSH (μIU/ml) 0.3–5 μIU/ml |
0.27 ± 0.26 | 0.68 ± 0.84 | 0.73 ± 0.81 | <0.001 |
∗Data were presented as mean ± SD and test of significance done by ANOVA Test.